Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 32 studies | 29% ± 12% | |
| mast cell | 17 studies | 29% ± 10% | |
| B cell | 15 studies | 25% ± 6% | |
| non-classical monocyte | 14 studies | 31% ± 13% | |
| conventional dendritic cell | 13 studies | 22% ± 6% | |
| monocyte | 12 studies | 34% ± 16% | |
| classical monocyte | 11 studies | 24% ± 8% | |
| myeloid cell | 11 studies | 36% ± 14% | |
| fibroblast | 11 studies | 28% ± 13% | |
| naive B cell | 10 studies | 25% ± 6% | |
| dendritic cell | 9 studies | 23% ± 5% | |
| endothelial cell | 9 studies | 47% ± 20% | |
| memory B cell | 9 studies | 25% ± 7% | |
| adipocyte | 9 studies | 42% ± 18% | |
| alveolar macrophage | 8 studies | 43% ± 16% | |
| astrocyte | 8 studies | 45% ± 19% | |
| glutamatergic neuron | 8 studies | 52% ± 19% | |
| oligodendrocyte | 8 studies | 41% ± 16% | |
| oligodendrocyte precursor cell | 8 studies | 41% ± 21% | |
| microglial cell | 8 studies | 40% ± 12% | |
| plasmacytoid dendritic cell | 7 studies | 29% ± 12% | |
| ciliated cell | 7 studies | 34% ± 12% | |
| natural killer cell | 6 studies | 18% ± 2% | |
| mononuclear phagocyte | 6 studies | 32% ± 5% | |
| smooth muscle cell | 6 studies | 27% ± 6% | |
| neuron | 6 studies | 34% ± 20% | |
| T cell | 6 studies | 38% ± 24% | |
| GABAergic neuron | 5 studies | 52% ± 11% | |
| amacrine cell | 5 studies | 57% ± 30% | |
| leukocyte | 5 studies | 35% ± 11% | |
| hepatocyte | 4 studies | 58% ± 28% | |
| pericyte | 4 studies | 22% ± 5% | |
| epithelial cell | 4 studies | 34% ± 8% | |
| cardiac muscle cell | 4 studies | 32% ± 6% | |
| CD8-positive, alpha-beta T cell | 4 studies | 20% ± 3% | |
| endothelial cell of lymphatic vessel | 4 studies | 40% ± 20% | |
| mature NK T cell | 4 studies | 27% ± 13% | |
| club cell | 4 studies | 31% ± 6% | |
| type I pneumocyte | 4 studies | 47% ± 14% | |
| type II pneumocyte | 4 studies | 40% ± 18% | |
| interneuron | 4 studies | 49% ± 19% | |
| hepatic stellate cell | 3 studies | 51% ± 19% | |
| precursor B cell | 3 studies | 21% ± 3% | |
| squamous epithelial cell | 3 studies | 51% ± 23% | |
| retinal cone cell | 3 studies | 42% ± 26% | |
| endocardial cell | 3 studies | 38% ± 8% | |
| mesothelial cell | 3 studies | 33% ± 7% | |
| tissue-resident macrophage | 3 studies | 38% ± 10% | |
| GABAergic amacrine cell | 3 studies | 75% ± 16% | |
| glycinergic amacrine cell | 3 studies | 56% ± 14% | |
| retinal ganglion cell | 3 studies | 31% ± 12% | |
| myofibroblast cell | 3 studies | 28% ± 6% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 25% ± 1% | |
| gamma-delta T cell | 3 studies | 25% ± 7% | |
| basal cell | 3 studies | 24% ± 3% | |
| CD4-positive, alpha-beta T cell | 3 studies | 19% ± 1% | |
| endothelial cell of artery | 3 studies | 22% ± 10% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 100% | 3172.02 | 578 / 578 | 99% | 6.68 | 1147 / 1155 |
| breast | 99% | 921.85 | 455 / 459 | 98% | 5.48 | 1091 / 1118 |
| kidney | 99% | 772.87 | 88 / 89 | 96% | 5.80 | 864 / 901 |
| liver | 100% | 2256.19 | 226 / 226 | 92% | 4.71 | 373 / 406 |
| intestine | 93% | 560.05 | 898 / 966 | 98% | 5.29 | 518 / 527 |
| prostate | 91% | 511.31 | 224 / 245 | 96% | 3.82 | 481 / 502 |
| stomach | 88% | 490.08 | 315 / 359 | 98% | 5.85 | 281 / 286 |
| esophagus | 85% | 725.34 | 1224 / 1445 | 100% | 5.48 | 183 / 183 |
| thymus | 89% | 494.27 | 581 / 653 | 95% | 5.25 | 577 / 605 |
| brain | 84% | 796.69 | 2227 / 2642 | 98% | 4.92 | 693 / 705 |
| ovary | 72% | 314.86 | 130 / 180 | 99% | 7.90 | 426 / 430 |
| uterus | 71% | 348.66 | 121 / 170 | 94% | 4.93 | 431 / 459 |
| bladder | 71% | 292.62 | 15 / 21 | 73% | 3.56 | 367 / 504 |
| skin | 72% | 2130.29 | 1305 / 1809 | 69% | 2.24 | 327 / 472 |
| adrenal gland | 74% | 367.17 | 190 / 258 | 60% | 2.33 | 139 / 230 |
| pancreas | 16% | 54.50 | 51 / 328 | 97% | 6.20 | 173 / 178 |
| spleen | 100% | 1534.19 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 7.37 | 45 / 45 |
| adipose | 99% | 1127.03 | 1197 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 95% | 682.93 | 1263 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 5.36 | 27 / 29 |
| peripheral blood | 59% | 541.98 | 547 / 929 | 0% | 0 | 0 / 0 |
| heart | 54% | 271.52 | 463 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 53% | 1.30 | 42 / 80 |
| muscle | 35% | 135.76 | 281 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007265 | Biological process | Ras protein signal transduction |
| GO_0030496 | Cellular component | midbody |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005770 | Cellular component | late endosome |
| GO_0005769 | Cellular component | early endosome |
| GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
| Gene name | RASGEF1B |
| Protein name | RasGEF domain family member 1B Ras-GEF domain-containing family member 1B (GPI gamma-4) RASGEF1B protein (RasGEF domain family member 1B) |
| Synonyms | GPIG4 |
| Description | FUNCTION: Guanine nucleotide exchange factor (GEF) with specificity for RAP2A, it doesn't seems to activate other Ras family proteins (in vitro). . |
| Accessions | A0A1B0GW78 ENST00000512716.1 ENST00000436139.6 Q8N437 ENST00000264400.7 [Q0VAM2-1] ENST00000509081.5 [Q0VAM2-3] A0A0G2JLL4 Q0VAM2 ENST00000638048.1 ENST00000335927.11 [Q0VAM2-2] ENST00000514050.6 D6RE71 ENST00000504863.1 A0A1B0GVA7 |